rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

SS Innovations International Inc.

SSII · Nasdaq

Health CareMedical DevicesNot moving yet

SSII stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 33.3% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$10.4M
Insider sales, 12 months
$200K
Officials’ trades on record
0
Institutions holding
21 (-3)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$11.2M$0$9.6MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months3
Sale orders, 12 months1
Buyers · sellers3 · 1
WhoDidSharesTraded
Srivastava SudhirChairman and CEOsold33,333at $3.004 Sep 2026filed 9 Sep 2026
Srivastava SudhirChairman and CEObought498,753at $4.016 Mar 2026filed 10 Mar 2026
Timothy P. AdamsDirectorbought300,000at $3.996 Mar 2026filed 10 Mar 2026
Frederic H. MollDirector, 10% ownerbought501,253at $3.996 Mar 2026filed 10 Mar 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders21-3 on the quarter
New · exited2 · 4
Reported value$6.3M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Hood River Capital Management LLCunchanged · filed 14 Aug 2026833,333$3.5M00.0%
Inspire Investing, LLCadded · filed 12 Aug 2026186,297$773K+81,673+78.1%
Eversept Partners, LPunchanged · filed 14 Aug 2026110,157$457K00.0%
JNBA Financial Advisorsreduced · filed 23 Jul 2026102,291$425K-14,646−12.5%
UBS Group AGreduced · filed 13 Aug 202651,208$213K-104,333−67.1%
AlphaCentric Advisors LLCunchanged · filed 24 Jul 202650,000$208K00.0%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 202641,771$173K+5,495+15.1%
Forum Financial Management, LPunchanged · filed 23 Jul 202638,469$160K00.0%
AlTi Global, Inc.unchanged · filed 5 Aug 202620,555$85K00.0%
Mariner, LLCadded · filed 13 Aug 202619,211$80K+554+3.0%
30 Jun 2025 – 30 Jun 2026
121824Jun 25Sep 25Dec 25Mar 26Jun 26

Everyone who traded it

Srivastava Sudhir Company insiderChairman and CEO · last 9 Oct 20261 · 12
Pascual Srivastava Vishwajyoti Company insiderCEO - Asia Pacific · last 4 Jun 20260 · 0
Barry F. Cohen Company insiderCOO - Americas · last 1 Jun 202636 · 0
Frederic H. Moll Company insiderDirector, 10% owner · last 6 Mar 20265 · 0
Timothy P. Adams Company insiderDirector · last 6 Mar 20264 · 0
Kumar Sethi Anup Company insiderCFO · last 7 Mar 20250 · 0
Sampige Prasannakumar Somashekar Company insiderDirector · last 31 Aug 20240 · 0

Same industry

RCEL Avita MedicalLeading+100%
ATRC AtriCureLeading+49%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202546.0%
Operating profit marginFY 2025 · to 31 Dec 2025-19.3%
Free cash flow marginFY 2025 · to 31 Dec 2025-52.3%
Return on capital employedFY 2025 · to 31 Dec 2025-17.1%
Interest coverFY 2025 · to 31 Dec 2025-30.17×
Research spendFY 2025 · to 31 Dec 20258.7%
Share count trendFY 2025 · to 9 Mar 20260.1%
Cash and equivalentsFY 2025 · to 31 Dec 2025$3.2M
Free cash flowFY 2025 · to 31 Dec 2025−$22.2M

Analyst forecasts

No analyst forecasts yet.